These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Peritoneal dialysis does not reduce serum porphyrin levels in porphyria cutanea tarda. Hebert AA; Farmer KL; Poh-Fitzpatrick MB Nephron; 1992; 60(2):240. PubMed ID: 1553013 [No Abstract] [Full Text] [Related]
9. Urinary porphyrins in liver disease. Ostrowski J; Kosecki P; Martyńska M; Milewski B Scand J Gastroenterol; 1984 Sep; 19(6):862-6. PubMed ID: 6515322 [TBL] [Abstract][Full Text] [Related]
10. [Results of clinical and chemical studies in porphyria cutanea tarda]. Formanek I; Niebauer G Wien Z Inn Med; 1966 Nov; 47(11):438-44. PubMed ID: 6005177 [No Abstract] [Full Text] [Related]
11. [Pattern of urinary porphyrins in porphyria cutanea tarda]. Finzi AF G Ital Dermatol Venereol; 1984; 119(3):155-6. PubMed ID: 6746007 [No Abstract] [Full Text] [Related]
12. Urinary porphyrin excretion in various types of porphyria. Thin-layer chromatographic study. Perrot H; Boucherat M; Gardella C Dermatologica; 1980; 161(3):167-78. PubMed ID: 7398995 [TBL] [Abstract][Full Text] [Related]
13. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism. Percy VA; Naidoo D; Joubert SM; Pegoraro RJ S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393 [TBL] [Abstract][Full Text] [Related]
14. Urinary porphyrin analyses in patients with porphyria cutanea tarda. Nonaka S; Ogami T; Yoshida K; Honda T; Murayama F; Yoshida H J Dermatol; 1982 Oct; 9(5):397-404. PubMed ID: 6761381 [No Abstract] [Full Text] [Related]
15. [Biochemistry of the regression and latent phase of porphyria cutanea tarda]. Peschlow I; Schlenzka K Dermatol Monatsschr; 1983 Feb; 169(2):85-91. PubMed ID: 6840368 [No Abstract] [Full Text] [Related]
16. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]. Seubert S; Seubert A; Stella AM; Guzman H; Batlle A Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575 [TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of D-glucaric acid, total glucuronic acid and total porphyrins in porphyria cutanea tarda. Budillon G; Ayala F; Carrella M; Mazzacca G Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):267-70. PubMed ID: 696201 [TBL] [Abstract][Full Text] [Related]
18. Biochemical differentiation of the porphyrias. Hindmarsh JT; Oliveras L; Greenway DC Clin Biochem; 1999 Nov; 32(8):609-19. PubMed ID: 10638943 [TBL] [Abstract][Full Text] [Related]
19. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda. To-Figueras J; Ozalla D; Mateu CH Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438 [TBL] [Abstract][Full Text] [Related]
20. Haemodialysis-related porphyria cutanea tarda and treatment by recombinant human erythropoietin. Yaqoob M; Smyth J; Ahmad R; McClelland P; Fahal I; Kumar KA; Yu R; Verbov J Nephron; 1992; 60(4):428-31. PubMed ID: 1584318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]